[Proper use of oral anticoagulants in the elderly patient]

Area of Science:

• Pharmacology and Therapeutics
• Cardiology
• Hematology

Context:

• Rising use of direct oral anticoagulants (DOACs) in elderly patients.
• Prevalence of atrial fibrillation and venous thromboembolism as common indications.
• Continued relevance of vitamin K inhibitors (VKAs) in specific clinical scenarios.

Purpose:

• To highlight the ongoing necessity of understanding vitamin K inhibitor (VKA) usage.
• To emphasize the risks associated with direct oral anticoagulants (DOACs).
• To address the particular challenges in managing anticoagulation in fragile patients with comorbidities and polypharmacy.

Summary:

• Direct oral anticoagulants (DOACs) are increasingly replacing vitamin K inhibitors (VKAs) for common indications like atrial fibrillation and venous thromboembolism, especially in elderly populations.
• Despite the shift towards DOACs, a thorough understanding of vitamin K inhibitor (VKA) management remains crucial as they retain important clinical roles.
• The study underscores that DOACs are not without risks and require careful handling, particularly in vulnerable patients with multiple health conditions and medications.

Impact:

• Informs clinical practice regarding the appropriate selection and management of anticoagulants.
• Promotes safer anticoagulation strategies for elderly and comorbid patients.
• Contributes to the evidence base for optimizing anticoagulant therapy in diverse patient populations.